Form D · Biotechnology

NuPulseCV, Inc.

Raleigh, NC · CIK 0001520888

Offering snapshot reported Mar 26, 2020 · SEC filing

Reported sold
$2.1M
Offering amount: $20M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 10, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 26, 2020Initial$2,100,757No comparison2SEC filing
Jul 3, 2018Amendment$5,381,991$901,740vs Jun 22, 201813SEC filing
Jun 22, 2018Initial$4,480,251No comparison13SEC filing
Aug 12, 2014Amendment$6,699,750$3,949,950vs Jun 18, 201413SEC filing
Jun 18, 2014Initial$2,749,800No comparison7SEC filing
May 17, 2011Initial$550,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-363693

Source: Form D, filed Mar 26, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Douglas Altschuler Director, Executive
Douglas Godshall Director
Valluvan Jeevanandam Director
Brian Novack Director
Brian Novak Director
Sonna Patel Raman Executive
Greg Scott Director
Richard Sherman Director
Alex Shlyankevich Director
Dirk Simmons Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5734 Trinity Road Suite 101
Raleigh, NC, 27607